Rob Cottrell (Cleveland Research)

Focus Areas4 topics

Pricing1Competitive Dynamics1Demand1Revenue Growth1

Trends2 quarters

Questions per Quarter

Questions

Challenging

Companies Covered

Question History2 questions

CRLCharles River Laboratories2 quarters

2025 Q3

Is the selected discounting that you all were discussing last year still a headwind year-over-year into the fourth quarter?

PricingCompetitive DynamicsView in transcript →

2025 Q1

you mentioned sales to small and midsized biotechs grew for the second consecutive quarter despite funding challenges. Was that the case across all 3 segments?

DemandRevenue GrowthView in transcript →